SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 8, 2026

INFU

InfuSystem Holdings, Inc
BULLISH
Impact 5/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $79K total
Actionable Insight ▲ Bullish

The CEO and CFO both buying stock immediately after earnings is a strong signal of internal conviction. While the dollar amount is modest relative to market cap, the joint C-suite buying after a mixed quarter with reaffirmed guidance suggests management sees the current price as undervalued. Monitor for additional insider purchases or a share buyback announcement.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
INFU ▲ +46.49% at T+60d
LONG call ✓ call won +46.49% · α vs SPY +41.65% · entry $8.41 → $12.32
Entry = T+0 close
May 7, 2026
via day close
T+1d
-0.48%
call -0.48% · α -0.71%
$8.37
settled 6mo ago
T+5d
+2.38%
call +2.38% · α +0.91%
$8.61
settled 6mo ago
T+20d
+9.87%
call +9.87% · α +9.85%
$9.24
settled 5mo ago
T+60d
+46.49%
call +46.49% · α +41.65%
$12.32
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

InfuSystem's CEO and CFO collectively purchased $79K of stock in open-market transactions on May 8 and May 11, 2026, following the Q1 2026 earnings release. The insider buying signals confidence after a mixed quarter where GAAP revenue declined 3% YoY but net income turned positive and full-year guidance was reaffirmed.

Key Financial Metrics

Direction
buying
Total Value
$87.0K
Insiders
2

Key Facts

  • CEO Carrie Lachance purchased 3,000 shares ($26,120 total) on May 8 and May 11 at $8.46-$8.83
  • CFO Barry Steele purchased 7,000 shares ($60,949) on May 8 at $8.707
  • Total insider buying of $87K represents 0.05% of INFU's $169M market cap
  • Q1 2026 revenue was $33.7M, down 3% YoY, but net income improved to $1.0M vs a loss of $0.3M
  • Full-year 2026 guidance reaffirmed for 6-8% pro-forma revenue growth and mid-to-low 20% Adjusted EBITDA margins

Financial Impact

$87K in insider purchases, representing 0.05% of market cap

insider ownershipmarket sentiment

Risk Factors

  • GAAP revenue declined 3% YoY due to GE Healthcare contract restructuring — top-line headwinds persist
  • Insider buying at only 0.05% of market cap is not material enough to move the stock alone

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INFU-1778592593804
10 reports for INFU
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for INFU — sortable, filterable
TypeNow
Aug 4, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$12.32 $12.46▲ +1.14%▲ +1.24%$13.89 (+12.70%)
Aug 4, 2026
11w ago
8-K
BULLISH ★ 6/10
$12.32 $12.46▲ +1.14%▲ +1.24%$13.89 (+12.70%)
Jul 28, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$9.92 $9.22▼ −7.06%▼ −9.33%$13.89 (+39.97%)
May 18, 2026
22w ago
8-K
NEUTRAL ★ 4/10
$9.67 $9.45▼ −2.28%▼ −4.52%$13.89 (+43.59%)
May 14, 2026
23w ago
8-K
NEUTRAL ★ 2/10
$8.61 $9.94▲ +15.45%▲ +16.16%$13.89 (+61.27%)
May 12, 2026
23w ago
8-K
NEUTRAL ★ 2/10
$8.21 $9.67▲ +17.78%▲ +18.94%$13.89 (+69.12%)
May 8, 2026
24w ago
Insider Cluster
BULLISH ★ 5/10
$8.41 $8.61▲ +2.38%▲ +0.91%$13.89 (+65.10%)
May 8, 2026
24w ago
Insider Cluster
BULLISH ★ 5/10
$8.41 $8.61▲ +2.38%▲ +0.91%$13.89 (+65.10%)
May 7, 2026
24w ago
8-K
MIXED ★ 5/10
$8.97 $8.21▼ −8.47%▼ −9.98%$13.89 (+54.79%)
Apr 30, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$10.13 $8.97▼ −11.45%▼ −13.18%$13.89 (+37.07%)
Showing 10 of 10

US Market Status

Market Open — Closes in 2h 25m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 12, 2026